Peripheral Arterial Disease Trial, Recruiting NCT06846658 Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06846658
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with Parkinson's Disease (a condition affecting movement and coordination)
  • People diagnosed with Multiple System Atrophy (a rare condition affecting the nervous system and movement)
  • People diagnosed with Dementia with Lewy Bodies (a type of dementia linked to abnormal protein deposits in the brain)
  • People diagnosed with certain Other Neurological Diseases (ONDs), including ataxia syndromes (conditions causing loss of coordination) where the cause is known, whether inherited or acquired
  • People diagnosed with Progressive Supranuclear Palsy (a rare brain condition affecting balance, movement, and eye control)
  • People diagnosed with Corticobasal Degeneration (a rare condition affecting movement and brain function)
  • People diagnosed with Motor Neuron Disease (a condition affecting the nerves that control movement)

Who may not be able to join:

  • No specific exclusion criteria have been listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Registry
ClinicalTrials.gov
Start date
3 October 2023
Est. completion
1 April 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Identify a predictive model for the diagnosis of PD, MSA and DLB

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov